Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

This distinction between true value and value traps can challenge even the most skilled investors. Luckily for you, we started StockStory to help you uncover exceptional companies. Keeping that in mind, here are two value stocks trading at big discounts to their intrinsic values and one best left ignored.

One Value Stock to Sell:

OceanFirst Financial (OCFC)

Forward P/B Ratio: 0.6x

Tracing its roots back to 1902 when it began serving coastal New Jersey communities, OceanFirst Financial (NASDAQ: OCFC) operates as a regional bank holding company that provides commercial and consumer banking services primarily in New Jersey and surrounding metropolitan areas.

Why Do We Steer Clear of OCFC?

1. Muted 3.1% annual net interest income growth over the last five years shows its demand lagged behind its banking peers
2. Annual earnings per share growth of 1.2% underperformed its revenue over the last five years, showing its incremental sales were less profitable
3. Capital strength will likely plateau over the next 12 months as Wall Street expects flat tangible book value per share

OceanFirst Financial’s stock price of $17.95 implies a valuation ratio of 0.6x forward P/B. Dive into our free research report to see why there are better opportunities than OCFC.

Two Value Stocks to Watch:

Elevance Health (ELV)

Forward P/E Ratio: 14x

Formerly known as Anthem until its 2022 rebranding, Elevance Health (NYSE: ELV) is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans.

Why Could ELV Be a Winner?

1. Decent 10.7% annual revenue growth over the last five years beat most of its peers, showing customers find value in its products and services
2. Massive revenue base of $193.3 billion gives it meaningful leverage when negotiating reimbursement rates
3. Stellar returns on capital showcase management’s ability to surface highly profitable business ventures

At $374.05 per share, Elevance Health trades at 14x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

Ameriprise Financial (AMP)

Forward P/E Ratio: 12.3x

Founded in 1894 and spun off from American Express in 2005, Ameriprise Financial (NYSE: AMP) provides financial planning, wealth management, asset management, and insurance products to help individuals and institutions achieve their financial goals.

Why Will AMP Outperform?

1. Share repurchases over the last five years enabled its annual earnings per share growth of 22.5% to outpace its revenue gains
2. Annual tangible book value per share growth of 35.5% over the past two years was outstanding, reflecting strong capital accumulation this cycle
3. Stellar return on equity showcases management’s ability to surface highly profitable business ventures

Ameriprise Financial is trading at $510.13 per share, or 12.3x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.